|
|||||
|
|
NICE guidance on erlotinib for first-line treatment of EGFR-TK mutation-positive advanced or metastatic non-small-cell lung cancer |
|
| Authors: | Bernice Dillon Bhash Naidoo Helen Knight Peter Clark |
| Affiliation: | 1. National Institute for Health and Clinical Excellence, Piccadilly Plaza, Manchester, UK |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |